Pharvaris’s Oral HAE Prevention Data May Threaten BioCryst’s Orladeyo

 
• By Joseph Haas
  
Oral vs injectable
Pharvaris hopes to compete with injectables and the other oral in HAE • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D